We are live on ! Find out more
MDT icon

Medtronic

1,958 hedge funds and large institutions have $128B invested in Medtronic in 2020 Q4 according to their latest regulatory filings, with 255 funds opening new positions, 832 increasing their positions, 653 reducing their positions, and 85 closing their positions.

New
Increased
Maintained
Reduced
Closed

200% more first-time investments, than exits

New positions opened: 255 | Existing positions closed: 85

27% more repeat investments, than reductions

Existing positions increased: 832 | Existing positions reduced: 653

13% more capital invested

Capital invested by funds: $113B → $128B (+$15.1B)

13% more funds holding in top 10

Funds holding in top 10: 6270 (+8)

8% more funds holding

Funds holding: 1,8111,958 (+147)

0.26% less ownership

Funds ownership: 81.08%80.82% (-0.26%)

13% less call options, than puts

Call options by funds: $878M | Put options by funds: $1.01B

Holders
1,958
Holders Change
+147
Holders Change %
+8.12%
% of All Funds
34.64%
Holding in Top 10
70
Holding in Top 10 Change
+8
Holding in Top 10 Change %
+12.9%
% of All Funds
1.24%
New
255
Increased
832
Reduced
653
Closed
85
Calls
$878M
Puts
$1.01B
Net Calls
-$134M
Net Calls Change
-$151M
Name Holding Trade Value Shares
Change
Change in
Stake
SPIA
401
Steward Partners Investment Advisory
New York
$13.1M +$1.29M +11,725 +12%
GIM
402
Grassi Investment Management
California
$13.1M -$296K -2,685 -2%
PF
403
Phoenix Financial
Israel
$13.1M +$9.76M +88,672 +381%
AI
404
Atria Investments
North Carolina
$13.1M +$1.91M +17,306 +18%
SCA
405
Stillwater Capital Advisors
Pennsylvania
$13M -$121K -1,100 -1%
ECG
406
Edge Capital Group
Georgia
$13M -$89.1K -809 -0.7%
WP
407
WealthPLAN Partners
Nebraska
$13M +$1.04M +9,434 +9%
Parallax Volatility Advisers
408
Parallax Volatility Advisers
California
$13M -$12M -109,320 -50%
GW
409
GW & Wade
Massachusetts
$12.9M +$158K +1,438 +1%
NB
410
Norinchukin Bank
Japan
$12.9M -$382K -3,469 -3%
NCM
411
Noesis Capital Mangement
Florida
$12.9M +$30.3K +275 +0.3%
IHL
412
Investment House LLC
California
$12.8M +$23.7K +215 +0.2%
BONST
413
Bank of Nova Scotia Trust
Ontario, Canada
$12.6M +$440K +3,994 +4%
FNT
414
First National Trust
Pennsylvania
$12.5M +$372K +3,376 +3%
MCM
415
McKinley Capital Management
Alaska
$12.5M
OPERF
416
Oregon Public Employees Retirement Fund
Oregon
$12.4M -$186K -1,688 -2%
RCYC
417
Richard C. Young & Co
Rhode Island
$12.3M +$197K +1,791 +2%
GH
418
GAM Holding
Switzerland
$12.2M -$9.86M -89,533 -46%
NIA
419
Northstar Investment Advisors
Colorado
$12.2M +$203K +1,842 +2%
CIA
420
CCM Investment Advisers
South Carolina
$12.2M -$63.4K -576 -0.6%
SCM
421
SKBA Capital Management
California
$12M +$1.19M +10,800 +12%
AssetMark Inc
422
AssetMark Inc
California
$11.9M +$205K +1,860 +2%
EIA
423
Edgemoor Investment Advisors
Maryland
$11.9M +$367K +3,331 +3%
PP
424
Prospector Partners
Connecticut
$11.8M -$38.5K -350 -0.3%
FDCDDQ
425
Federation des caisses Desjardins du Quebec
Quebec, Canada
$11.7M +$392K +3,565 +4%

MDT Hedge Fund Activity: Q4 2020 in Review

1,958 of the 5,652 institutional investors tracked by Wall St. Rank reported a position in Medtronic (MDT) for Q4 2020, worth a combined $128B — up 13% from $113B a quarter earlier.

Buyers outnumbered sellers: 255 funds opened new MDT positions and 85 closed out — a net gain of 170 holders — while 832 added to existing stakes and 653 trimmed.

The largest buyer was T. Rowe Price Associates, adding an estimated $317M. The largest seller was Wellington Management Group, cutting an estimated $636M.

  • 1,958 institutional investors held Medtronic (MDT) as of Q4 2020, up from 1,811 in Q3 2020.
  • Funds reported $128B of Medtronic stock for Q4 2020, up 13% quarter-over-quarter.
  • 255 funds opened new Medtronic positions in Q4 2020 and 85 closed out, a net change of +170 holders.
  • The largest Medtronic buyer in Q4 2020 was T. Rowe Price Associates, an estimated $317M added.
  • The largest Medtronic seller in Q4 2020 was Wellington Management Group, an estimated $636M sold.

Based on aggregated 13F filings for Q4 2020.